|
Challenges ... Opportunities ... Now, more than ever, life sciences organizations are at a crossroads.
The key to overcoming industry challenges and capitalizing on new opportunities lies in an organization's ability to access relevant, accurate information that can be used to make informed business decisions with clarity and confidence. Enter SAS Drug Development.
SAS Drug Development provides a centralized, integrated system for managing, analyzing, reporting and reviewing clinical research information. The solution enables life sciences organizations to make informed business decisions with confidence, to assess the safety and efficacy of research compounds more effectively, to collaborate across trials, phases and therapeutic areas successfully, and ultimately get better products to market faster.
SAS Drug Development enables significant efficiency and productivity improvements within your R&D organizations, which translate into decreased development costs, a faster time-to-market and improved earnings.
Drawing on the power of the SAS®9 Intelligence Platform, SAS Drug Development specifically addresses the compliance requirements of life sciences organizations, while supporting your business objectives and aims to:
- Integrate molecular information with clinical outcomes.
- Deliver better therapies to market more quickly.
- Control costs.
- Comply with increasing regulatory requirements.
- Collaborate globally.
- Build a centralized, searchable repository of all research information.
- Assess safety and efficacy more effectively.
- Meet shareholder expectations.
- Optimize efficiency and productivity across the life sciences value chain.
|
SAS Drug Development's secure, collaborative framework puts controlled power into the hands of researchers who need it. The result is greater productivity and efficiency in these areas:
- Integration. Efficiently integrate and manage data from a wide range of sources – such as electronic data capture (EDC) systems, in-house clinical data management systems (CDMS), labs and contract research organizations (CROs) – while leveraging investments in existing systems and resources.
- Analysis and reporting. Accurately assess and report on study data in a timely manner. Efficiently generate presentation-ready statistical summaries of clinical trials data and easily share results with researchers or reviewers on demand.
- Discovery. Use your growing research information repository to rapidly investigate critical drug safety issues, pursue new marketing claims and explore potential product-line extensions.
- Regulatory compliance. Document research content via integrated processes that provide versioning, audit trails and electronic signatures, as well as fully describing the relationships between all process inputs, transformations, analyses and results.
Globally recognized as the industry leader in analytics, the de facto standard for clinical data analysis, the FDA standard for electronic submissions and the choice of 100 percent of the Fortune 500 pharmaceutical companies, SAS assures accurate, consistent and reliable analysis of all your business information. SAS solutions for life sciences will meet your specific needs today and grow with your business strategies for tomorrow.
|
Industries
Aerospace
